![]() |
ZIOPHARM initiates ZIN ATI-001 Phase 1 clinical study in advanced melanoma
ZIOPHARM Oncology, Inc. today announced that the first patient has been dosed in a Phase 1 clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate, in patients with advanced melanoma.
More... |
| All times are GMT -7. The time now is 11:48 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021